Related Experiment Video
Updated: Aug 14, 2026
11:06
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
A Metabolism-Guided Framework for Selecting Structural Modification or Nano-Delivery Strategies for Oral Rutin
Ting He1, Ying Wang1, Fei Yan1
1Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
International Journal of Molecular Sciences
|August 13, 2026
Summary
Rutin
Area of Science:
- Pharmacology and Drug Delivery
- Nutraceuticals and Natural Products
- Microbiome Research
Background:
- Rutin, a flavonoid glycoside, exhibits antioxidant and anti-inflammatory properties.
- Poor oral bioavailability of rutin is attributed to extensive presystemic metabolism.
- Gut microbiota metabolize rutin into active compounds in the colon.
Purpose of the Study:
- To propose a metabolism-oriented framework for designing oral rutin delivery systems.
- To compare nano-delivery and structural modification strategies for rutin.
- To challenge conventional formulation approaches focusing solely on parent compound exposure.
Main Methods:
- Literature review and synthesis of preclinical and clinical data.
- Conceptual reclassification of nano-delivery systems based on ADME objectives.
- Comparative analysis of delivery strategies regarding pharmacokinetics, metabolism, safety, and feasibility.
Main Results:
- Rutin's colonic metabolism by gut microbiota can be viewed as a prodrug activation system.
- Nano-delivery systems can be categorized by their pharmacokinetic goals (ADME-oriented).
- Limited human pharmacokinetic data and lack of EFSA-authorized health claims for rutin exist.
Conclusions:
- A metabolism-focused framework is proposed for selecting oral rutin delivery strategies.
- This approach prioritizes metabolic objectives over simple solubility or systemic exposure enhancement.
- Further human metabolite-resolved pharmacokinetic studies are needed to guide rutin delivery.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Factors Influencing Drug Absorption: Presystemic Elimination
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...